Li-Ping Ge

Li-Ping Ge

Auto-generated profile, based on publicly available information

Li-Ping Ge

Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Institutes of Biomedical Sciences, Fudan University Shanghai Cancer Center, Shanghai Stomatological Hospital, and Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2023 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
Qinqin HuQinqin Hu
Qinqin Hu
ZTZongxuan Tong
Zongxuan Tong
AYAyimukedisi Yalikong
Ayimukedisi Yalikong
LGLi-Ping Ge
Li-Ping Ge
QSQiang Shi
Qiang Shi
HGHongzhou Gu
Hongzhou Gu

1 October 2018 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
LGLi-Ping Ge
Li-Ping Ge
XLXi-Yu Liu
Xi-Yu Liu
YXYi Xiao
Yi Xiao
ZGZong-Chao Gou
Zong-Chao Gou
SZShen Zhao
Shen Zhao
GDGen-Hong Di
Gen-Hong Di
Background: Occult breast cancer (OBC) is a rare type of breast cancer that has not been well studied. The clinicopathological characteristics and treatment recommendations for OBC are based on a limited number of retrospective studies and thus remain controversial. Patients and methods: We identified 479 OBC patients and 115,739 non-OBC patients from 2004 to 2014 in and the Surveillance, Epidemiology, and End Results (SEER) database. The clinicopathological characteristics and survival outcomes were compared between OBC and non-OBC patients. We used the propensity score 1:1 matching analysis to evaluate OBC vs non-OBC comparison using balanced groups with respect to the observed covariates. We further divided the OBC population into four groups based on different treatment strategies. Univariable and multivariable analyses were used to calculate and compare the four treatment outcomes within the OBC population. Results: OBC patients were older, exhibited a more advanced stage, a higher rate of negative estrogen receptor and progesterone receptor status, a higher rate of HER2-positive status, and a higher rate of ≥10 positive lymph nodes, and were less likely to undergo surgical treatment than non-OBC patients. After adjustments for clinicopathological factors, the OBC patients exhibited a significantly better survival than the non-OBC patients (P<0.001). This result was confirmed in a 1:1 matched case–control analysis. Within the four OBC treatment groups, we observed no difference in survival among the mastectomy group, the breast-conserving surgery (BCS) group, and the axillary lymph node dissection (ALND)-only group. The multivariable analysis revealed that the sentinel lymph node dissection-only group had the worst prognosis (P<0.001). Conclusion: OBC has unique clinicopathological characteristics and a favorable prognosis compared with non-OBC. BCS plus ALND and radiotherapy showed a survival benefit that was similar to that of mastectomy for OBC patients.

2 March 2021 in Oncogene
Verified
Journal Article
Closed access
PDF file
LGLi-Ping Ge
Li-Ping Ge
XJXi Jin
Xi Jin
YYYun-Song Yang
Yun-Song Yang
XLXi-Yu Liu
Xi-Yu Liu
ZSZhi-Ming Shao
Zhi-Ming Shao
YJYi-Zhou Jiang
Yi-Zhou Jiang

29 December 2003 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JZJinbiao Zhan
Jinbiao Zhan
LGLiping Ge
Liping Ge
JSJiangen Shen
Jiangen Shen
KWKeyi Wang
Keyi Wang
SZShu Zheng
Shu Zheng